{"nctId":"NCT00399542","briefTitle":"Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation","startDateStruct":{"date":"2005-05"},"conditions":["Irritable Bowel Syndrome","Constipation"],"count":581,"armGroups":[],"interventions":[{"name":"Lubiprostone","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 18 years of age and older\n* Stable fiber therapy\n* Normal colonoscopy/sigmoidoscopy\n* Able to refrain from use of medications known to treat or associated with constipation symptoms\n* Experiences abdominal discomfort/pain associated with bowel movements\n* Reports decreased bowel movement frequency and/or other symptoms associated with constipation\n\nExclusion Criteria:\n\n* Diarrhea-predominant or alternating (diarrhea \\& constipation cycling) IBS, or constipation other than that associated with IBS\n* Open gastrointestinal or abdominal surgery prior to IBS onset\n* Organic bowel disorder, mechanical bowel obstruction, pseudo-obstruction, unexplained weight loss or rectal bleeding\n* Uncontrolled cardiovascular, liver or lung disease, neurologic or psychiatric disorder, other systemic disease, or abnormal laboratory tests per investigator discretion\n* If female, is currently pregnant or nursing, or plans to become pregnant or nurse during the clinical study","sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Overall Responder Status","description":"Overall responder: monthly responder for at least 2 out of 3 months\n\nMonthly responder: \\>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \\>= 2 weeks/month IF:\n\nRescue med use did not increase; AND patient did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.1","spread":null},{"groupId":"OG001","value":"5.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Month 1 Spontaneous Bowel Movement Rates Change From Baseline","description":"Any bowel movement not associated with rescue medication use","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.55","spread":"3.071"},{"groupId":"OG001","value":"1.29","spread":"2.934"}]}]}]},{"type":"SECONDARY","title":"Month 1 Stool Consistency Change From Baseline","description":"0 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.673"},{"groupId":"OG001","value":"-0.37","spread":"0.582"}]}]}]},{"type":"SECONDARY","title":"Month 1 Bowel Straining Change From Baseline","description":"0 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.54","spread":"0.719"},{"groupId":"OG001","value":"-0.42","spread":"0.628"}]}]}]},{"type":"SECONDARY","title":"Month 1 Constipation Severity Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.41","spread":"0.606"},{"groupId":"OG001","value":"-0.33","spread":"0.495"}]}]}]},{"type":"SECONDARY","title":"Month 1 Symptom Relief","description":"* 3 = Significantly worse, -2 = Moderately worse,\n* 1 = A little bit worse, 0 = Unchanged, 1 = A little bit relieved, 2 = Moderately relieved, 3 = Significantly relieved","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","spread":"1.058"},{"groupId":"OG001","value":"0.60","spread":"1.043"}]}]}]},{"type":"SECONDARY","title":"Month 1 Responder Rate","description":"Monthly responder: \\>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \\>= 2 weeks/month IF:\n\nRescue med use did not increase; AND patient did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.8","spread":null},{"groupId":"OG001","value":"6.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Month 2 Responder Rate","description":"Monthly responder: \\>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \\>= 2 weeks/month IF:\n\nRescue med use did not increase; AND patient did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.1","spread":null},{"groupId":"OG001","value":"9.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Month 3 Responder Rate","description":"Monthly responder: \\>=Moderately relieved symptoms 4 weeks/month or Significantly relieved \\>= 2 weeks/month IF:\n\nRescue med use did not increase; AND patient did not discontinue during the month for lack of efficacy; AND no Moderately worse or Significantly worse response in month.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.5","spread":null},{"groupId":"OG001","value":"5.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Month 1 Abdominal Pain Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.32","spread":"0.600"},{"groupId":"OG001","value":"-0.29","spread":"0.450"}]}]}]},{"type":"SECONDARY","title":"Month 2 Abdominal Pain Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","spread":"0.707"},{"groupId":"OG001","value":"-0.33","spread":"0.601"}]}]}]},{"type":"SECONDARY","title":"Month 3 Abdominal Pain Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.47","spread":"0.746"},{"groupId":"OG001","value":"-0.35","spread":"0.619"}]}]}]},{"type":"SECONDARY","title":"Month 1 Abdominal Bloating Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.31","spread":"0.614"},{"groupId":"OG001","value":"-0.28","spread":"0.430"}]}]}]},{"type":"SECONDARY","title":"Month 2 Abdominal Bloating Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"0.741"},{"groupId":"OG001","value":"-0.33","spread":"0.611"}]}]}]},{"type":"SECONDARY","title":"Month 3 Abdominal Bloating Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.45","spread":"0.760"},{"groupId":"OG001","value":"-0.35","spread":"0.641"}]}]}]},{"type":"SECONDARY","title":"Month 2 Spontaneous Bowel Movement Rates Change From Baseline","description":"Any bowel movement not associated with rescue medication use","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.61","spread":"3.191"},{"groupId":"OG001","value":"1.39","spread":"3.495"}]}]}]},{"type":"SECONDARY","title":"Month 3 Spontaneous Bowel Movement Rates Change From Baseline","description":"Any bowel movement not associated with rescue medication use","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.43","spread":"3.061"},{"groupId":"OG001","value":"1.42","spread":"3.584"}]}]}]},{"type":"SECONDARY","title":"Month 2 Stool Consistency Change From Baseline","description":"0 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.50","spread":"0.700"},{"groupId":"OG001","value":"-0.41","spread":"0.724"}]}]}]},{"type":"SECONDARY","title":"Month 3 Stool Consistency Change From Baseline","description":"0 = Very loose (watery), 1 = Loose, 2 = Normal, 3 = Hard, 4 = Very hard (little balls)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.49","spread":"0.686"},{"groupId":"OG001","value":"-0.39","spread":"0.748"}]}]}]},{"type":"SECONDARY","title":"Month 2 Bowel Straining Change From Baseline","description":"0 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.62","spread":"0.817"},{"groupId":"OG001","value":"-0.50","spread":"0.745"}]}]}]},{"type":"SECONDARY","title":"Month 3 Bowel Straining Change From Baseline","description":"0 = Absent,1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.63","spread":"0.813"},{"groupId":"OG001","value":"-0.50","spread":"0.803"}]}]}]},{"type":"SECONDARY","title":"Month 2 Constipation Severity Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.51","spread":"0.732"},{"groupId":"OG001","value":"-0.42","spread":"0.664"}]}]}]},{"type":"SECONDARY","title":"Month 3 Constipation Severity Change From Baseline","description":"0 = Absent, 1 = Mild, 2 = Moderate, 3 = Severe, and 4 = Very Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.53","spread":"0.760"},{"groupId":"OG001","value":"-0.42","spread":"0.679"}]}]}]},{"type":"SECONDARY","title":"Month 2 Symptom Relief","description":"* 3 = Significantly worse, -2 = Moderately worse,\n* 1 = A little bit worse, 0 = Unchanged, 1 = A little bit relieved, 2 = Moderately relieved, 3 = Significantly relieved","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.79","spread":"1.140"},{"groupId":"OG001","value":"0.55","spread":"1.256"}]}]}]},{"type":"SECONDARY","title":"Month 3 Symptom Relief","description":"* 3 = Significantly worse, -2 = Moderately worse,\n* 1 = A little bit worse, 0 = Unchanged, 1 = A little bit relieved, 2 = Moderately relieved, 3 = Significantly relieved","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":"1.249"},{"groupId":"OG001","value":"0.56","spread":"1.222"}]}]}]},{"type":"SECONDARY","title":"Month 3 Quality of Life Change From Baseline","description":"IBS-QOL questionnaire included 34 questions with 5 possible responses yielding the following sub-categories: dysphoria, interference with activity, body image, health worry, food avoidance, social reaction, sexual, and relationship Results range from 34 (low) to 100 (high); meaningful clinical improvement=14 point increase","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","spread":"17.46"},{"groupId":"OG001","value":"13.4","spread":"16.26"}]}]}]},{"type":"SECONDARY","title":"Month 1 Bowel Movement Rates Change From Baseline","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.30","spread":"2.787"},{"groupId":"OG001","value":"0.87","spread":"3.104"}]}]}]},{"type":"SECONDARY","title":"Month 2 Bowel Movement Rates Change From Baseline","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.29","spread":"2.875"},{"groupId":"OG001","value":"0.95","spread":"3.444"}]}]}]},{"type":"SECONDARY","title":"Month 3 Bowel Movement Rates Change From Baseline","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.17","spread":"2.757"},{"groupId":"OG001","value":"0.97","spread":"3.309"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2},"commonTop":["Nausea","Diarrhoea","Headache"]}}}